Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Thongchai Pratipanawatr"'
Autor:
Thanyaporn Senarai, Thongchai Pratipanawatr, Laphatrada Yurasakpong, Nutmethee Kruepunga, Jarukitt Limwachiranon, Phetcharat Phanthong, Krai Meemon, Kaissar Yammine, Athikhun Suwannakhan
Publikováno v:
Medicina, Vol 58, Iss 12, p 1696 (2022)
Background: There is a link between diabetic peripheral neuropathy (DPN) progression and the increase in the cross-sectional area (CSA) of the tibial nerve at the ankle. Nevertheless, no prior meta-analysis has been conducted to evaluate its usefulne
Externí odkaz:
https://doaj.org/article/7ac7d85acb644919a335efe7d287d24b
Autor:
Bancha Satirapoj, Thongchai Pratipanawatr, Boonsong Ongphiphadhanakul, Sompongse Suwanwalaikorn, Yupin Benjasuratwong, Wannee Nitiyanant
Publikováno v:
BMJ Open, Vol 10, Iss 2 (2020)
ObjectivePatients with type 2 diabetes mellitus (T2DM) often experience hypoglycaemia and weight gain due to treatment side effects. Sulfonylureas (SU) and the combination of SU and metformin (SU+MET) were the most common monotherapy and combination
Externí odkaz:
https://doaj.org/article/941c55c99c274f6bbce8359c5b92d45a
Autor:
Thongchai Pratipanawatr, Bancha Satirapoj, Boonsong Ongphiphadhanakul, Sompongse Suwanwalaikorn, Wannee Nitiyanant
Publikováno v:
Journal of Diabetes Research, Vol 2019 (2019)
Type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases. Patients are generally advised lifestyle changes with antihyperglycemic agents prescribed. The major drawback of prescribing antihyperglycemic agents is the risk of hypoglyce
Externí odkaz:
https://doaj.org/article/0c0a2d04bede48faad5cbc33daf0b187
Autor:
Supawinee Pongpunna, Kamonphat Wongtaweepkij, Thongchai Pratipanawatr, Narumol Jarernsiripornkul
Publikováno v:
Pharmacy Practice. 20:01-10
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::767fd251285e5c4522df4eaab7924a8d
https://doi.org/10.18549/pharmpract.2022.4.2730
https://doi.org/10.18549/pharmpract.2022.4.2730
Autor:
Narumol Jarernsiripornkul, Supawinee Pongpunna, Kamonphat Wongtaweepkij, Thongchai Pratipanawatr
Publikováno v:
Patient preference and adherence
Supawinee Pongpunna,1 Thongchai Pratipanawatr,2 Kamonphat Wongtaweepkij,3 Narumol Jarernsiripornkul1 1Division of Clinical Pharmacy, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand; 2Department of Medicine, Faculty of Me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace6edd865646e946d6991fcf50b95a4
https://pubmed.ncbi.nlm.nih.gov/34737553
https://pubmed.ncbi.nlm.nih.gov/34737553
Autor:
Parinya Chamnan, Swangjit Suraamornkul, Seonghui Choi, Sam Kwon, Chaicharn Deerochanawong, Sung-Rae Kim, Sunun Benjachareonwong, Samroeng Seekaew, Natapong Kosachunhanun, Woo Je Lee, Thongchai Pratipanawatr, Sompongse Suwanwalaikorn, Young Min Cho, Tae Keun Oh, Eun Seok Kang, Moon Kyu Lee, Thanitha Sirirak, Sarinya Sattanon
Publikováno v:
Diabetes, Obesity and Metabolism. 22:123-127
The objective of this study was to evaluate the efficacy and safety of gemigliptin added to a stable dose of insulin alone or of insulin in combination with metformin in patients with type 2 diabetes mellitus. After a two-week run-in period, patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2782b46bc6d87b9ded39ba7c8aeb55bf
https://doi.org/10.1111/dom.13873
https://doi.org/10.1111/dom.13873
Autor:
Yupin Benjasuratwong, Bancha Satirapoj, Thongchai Pratipanawatr, Wannee Nitiyanant, Sompongse Suwanwalaikorn, Boonsong Ongphiphadhanakul
Publikováno v:
BMJ Open
BMJ Open, Vol 10, Iss 2 (2020)
BMJ Open, Vol 10, Iss 2 (2020)
ObjectivePatients with type 2 diabetes mellitus (T2DM) often experience hypoglycaemia and weight gain due to treatment side effects. Sulfonylureas (SU) and the combination of SU and metformin (SU+MET) were the most common monotherapy and combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04ad302c0c35b4ef74d124e25b190594
http://europepmc.org/articles/PMC7045111
http://europepmc.org/articles/PMC7045111
Autor:
Sung-Rae Kim, Tae Keun Oh, Sompongse Suwanwalaikorn, Parinya Chamnan, Sunun Benjachareonwong, Chaicharn Deerochanawong, Thongchai Pratipanawatr, Sam Kwon, Woo Je Lee, Thanitha Sirirak, Samroeng Seekaew, Sarinya Sattanon, Natapong Kosachunhanun, Eun Seok Kang, Moon-Kyu Lee, Young Min Cho, Seonghui Choi, Swangjit Suraamornkul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3a7187a612fbcaa58b4b4bfab5a24083
https://doi.org/10.1111/dom.13873/v2/response1
https://doi.org/10.1111/dom.13873/v2/response1
Publikováno v:
International journal of clinical pharmacy. 40(6)
Background Patient reporting of adverse drug reactions (ADRs) could supplement the existing reporting system and contribute to early detection of ADRs. The confidence in ADR identification and their attribution of ADRs were limited to outpatients. Ob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2583461958458f8f7f92afbdea422044
https://pubmed.ncbi.nlm.nih.gov/30367372
https://pubmed.ncbi.nlm.nih.gov/30367372
Publikováno v:
International journal of clinical pharmacy. 41(1)
Background Patient information leaflets are important sources of medicine information. Regulations of patient information leaflet provision varies among country. Little is known regarding patients’ behavior and expectation on use of patient informa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0616041878303087c127b6b612796eef
https://pubmed.ncbi.nlm.nih.gov/30446897
https://pubmed.ncbi.nlm.nih.gov/30446897